Search results
May 24, 2022 · SUMMARY. Systemic sclerosis, also called scleroderma, is a complex, multisystem rheumatic condition which has high variability in disease presentation and trajectory. It is characterized by immune dysregulation, vasculopathy, and progressive fibrosis that typically affects the skin and internal organs.
- 2022/05/24
May 1, 2005 · In this second edition of The Scleroderma Book, Dr Maureen Mayes—the leading authority in the field—draws on her extensive experience treating scleroderma to provide up-to-date, practical information that will help patients manage their symptoms and improve their quality of life.
People also ask
What is the Scleroderma Research Foundation?
What is scleroderma journal?
How many studies are there for scleroderma?
Apr 2, 2016 · The journal publishes high quality, original research articles on the epidemiology, natural history, pathophysiology, diagnosis, treatment and outcome of these diseases. View full journal description. This journal is a member of the Committee on Publication Ethics (COPE).
Overview. Editors: Yannick Allanore, John Varga, Christopher P. Denton, Masataka Kuwana, Lorinda Chung, Ami A. Shah. Fully updated third edition. Provides a concise synthesis of pathogenesis and modern approaches to management of systemic sclerosis. Presents an integrated multidisciplinary approach to comprehensive patient care. 241 Accesses.
May 5, 2021 · Therapeutic options for systemic sclerosis–related cutaneous disease. New trials and increased understanding of pathogenesis have produced a number of promising therapies for SSc-related skin disease (Table 1). Each of these may be considered depending on SSc subtype, status of extracutaneous organ involvement, and stage of evolution of skin ...
- Jane L Zhu, Samantha M Black, Henry W Chen, Heidi T Jacobe
- 10.12703/r/10-43
- 2021
- Fac Rev. 2021; 10: 43.
The Scleroderma Research Foundation funds research aimed at understanding the pathogenesis of scleroderma and promoting the design, development, and pilot-testing of hypothesis-driven, innovative, therapeutic approaches.
Mar 6, 2024 · Hayakazu Sumida. Research Open Access 06 Mar 2024 Scientific Reports. Volume: 14, P: 5572. GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor...